Clue For Development Of Diagnosis, Treatment Alzheimer's Disease

Clue For Development Of Diagnosis, Treatment Alzheimer's Disease

Article
Brain & Nerve
Laboratory Procedures
+1
Contributed byKrish Tangella MD, MBAMay 27, 2016

Kichitaro Nakajima, a graduate student at the Graduate School of Engineering Science, Hirotsugu Ogi, Associate Professor at the Graduate School of Engineering Science, and Yuji Goto, Professor at Institute for Protein Research, Osaka University succeeded in increasing the velocity constant for a reaction in which proteins causing Alzheimer disease (AD) turn into toxic substances to 1,000 times by using optimum frequency of ultrasonic irradiation.

When an ultrasonic wave is irradiated in solution with proteins, cavitation bubbles often repeatedly grow and collapse. This group found that these bubbles collect harmless proteins in solution, generating toxic substances whenever they collapse, changing into aggregates. This group also found that this phenomenon became prominent at the frequency of about 30 kHz.

It is thought Amyloid-β peptides form neurotoxic aggregates in the brain, developing AD. In developing drugs, it's important to identify and create toxic aggregates and explore drug candidates targeting them, but formation of Aβ aggregates often takes a very long time. Therefore, technology for accelerating the aggregation reaction in low concentrations has been greatly sought after.

Accelerating the aggregation reaction of Amyloid-β is also important in giving a diagnosis. For early detection of AD, it's effective to evaluate the aggregation capacity of Amyloid-β. Individuals who have an internal environment in which Amyloid-β tends to aggregate have a high risk of developing AD. However, it's difficult to aggregate Amyloid-β in the body, so technology for accelerating the aggregation reaction is required.

In recent years, it was found that ultrasonic irradiation increases the aggregation reaction of various proteins. Using their own ultrasonic irradiation device, this group explored conditions for enhancing aggregation of Amyloid-β by changing acoustic pressure and frequency in solution independently and accurately.

As a result, this group succeeded in increasing the reaction velocity constant to 1,000 times by optimizing acoustic pressure at a frequency of 30 kHz.

Furthermore, this group found out that this acceleration phenomenon was brought on by cavitation bubbles which generate and collapse along with the cycle of ultrasonic waves and succeeded in theoretically reproducing this phenomenon.

This group's achievement can be applied to techniques for early diagnosis of AD and demonstrates the conditions for reducing various risks associated with diagnosis and treatment using ultrasonic waves.



The above post is reprinted from materials provided by Osaka University.Note: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Nakajima, K., Ogi, H., Adachi, K., Noi, K., Hirao, M., Yagi, H., & Goto, Y. (2016). Nucleus factory on cavitation bubble for amyloid β fibril. Scientific reports6.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!